iData Insights

ORCA Therapeutics B.V. - Product Pipeline Review – 2015

Press Release   •   Dec 07, 2015 14:15 IST

ORCA Therapeutics B.V. - Product Pipeline Review - 2015 Summary Global Markets Direct s, ORCA Therapeutics B.V. - Product Pipeline Review - 2015, provides an overview of the ORCA Therapeutics B.V.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of ORCA Therapeutics B.V.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of ORCA Therapeutics B.V. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of ORCA Therapeutics B.V.s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the ORCA Therapeutics B.V.s pipeline products Reasons to buy - Evaluate ORCA Therapeutics B.V.s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of ORCA Therapeutics B.V. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the ORCA Therapeutics B.V.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of ORCA Therapeutics B.V. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of ORCA Therapeutics B.V. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of ORCA Therapeutics B.V. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues

Browse Complete Report with TOC @

To Get Sample Copy of Report visit @

Table of Contents

Table of Contents

2 List of Tables

4 List of Figures

4 ORCA Therapeutics B.V. Snapshot

5 ORCA Therapeutics B.V. Overview

5 Key Information 5 Key Facts

5 ORCA Therapeutics B.V. Research and Development Overview

6 Key Therapeutic Areas

6 ORCA Therapeutics B.V. Pipeline Review

8 Pipeline Products by Stage of Development 8 Pipeline Products Monotherapy

9 ORCA Therapeutics B.V. Pipeline Products Glance

10 ORCA Therapeutics B.V. Clinical Stage Pipeline Products

10 Phase I Products/Combination Treatment Modalities

10 ORCA Therapeutics B.V. Early Stage Pipeline Products

11 Preclinical Products/Combination Treatment Modalities

11 Discovery Products/Combination Treatment Modalities

12 ORCA Therapeutics B.V. Drug Profiles

13 ORCA-010

13 Product Description 13 Mechanism of Action

13 R&D Progress

13 Oncolytic Viruses to Activate p53 for Cancer

15 Product Description

15 Mechanism of Action

15 R&D Progress

15 Oncolytic Virus for Cancer

16 Product Description

16 Mechanism of Action

16 R&D Progress

16 ORCA Therapeutics B.V. Pipeline Analysis

17 ORCA Therapeutics B.V. Pipeline Products by Target

17 ORCA Therapeutics B.V. Pipeline Products by Molecule Type

18 ORCA Therapeutics B.V. Pipeline Products by Mechanism of Action

19 ORCA Therapeutics B.V. Dormant Projects

20 ORCA Therapeutics B.V. Locations And Subsidiaries

21 Head Office 21 Other Locations & Subsidiaries

21 Appendix

22 Methodology

22 Coverage

22 Secondary Research

22 Primary Research

22 Expert Panel Validation

22 Contact Us

22 Disclaimer

Read More @

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.

Contact Us:
iData Insights

Tel: 1-866-237-2965


AboutiData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects.